Skip to main content
    R

    Rocket Pharmaceuticals Inc (RCKT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.16
    -0.14 (-6.09%)

    Market Cap: $256.82M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Rocket Pharmaceuticals Inc (RCKT) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Rocket Pharmaceuticals (RCKT) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Rocket Pharmaceuticals reported EPS of -$0.43, below the -$0.39 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(23/39)
    Avg Surprise
    -6.10%

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.42
    Range-$0.45 - -$0.25
    15 analysts
    Revenue Consensus
    $612.00K
    RangeN/A
    13 analysts

    Next Report

    RCKT has an expected report date of Feb 24, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, RCKT beat 23, missed 15 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 153.57% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.43-$0.39-$0.43 - -$0.35-10.26%MissN/A52 up, 1 downNov 12, 2026
    Jun 30, 2026-$0.15$0.28-$0.54 - $1.15-153.57%MissN/A82 up, 1 downAug 10, 2026
    Mar 31, 2026-$0.42-$0.43-$0.52 - -$0.39+2.33%BeatN/A51 up, 0 downMay 7, 2026
    Dec 31, 2025-$0.38-$0.42-$0.56 - -$0.31+9.52%BeatN/A113 up, 4 downFeb 26, 2026
    Sep 30, 2025-$0.45-$0.52-$0.60 - -$0.38+13.46%BeatN/A141 up, 1 downNov 6, 2025
    Jun 30, 2025-$0.59-$0.57-$0.60 - -$0.15-3.51%MissN/A161 up, 0 downAug 7, 2025
    Mar 31, 2025-$0.56-$0.58-$0.82 - -$0.23+3.45%BeatN/A132 up, 0 downMay 8, 2025
    Dec 31, 2024-$0.62-$0.72-$0.80 - -$0.62+13.64%BeatN/A132 up, 0 downFeb 27, 2025
    Sep 30, 2024-$0.71-$0.75-$0.84 - -$0.65+5.33%BeatN/A150 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.74-$0.72-$0.82 - -$0.57-2.78%MissN/A141 up, 0 downAug 5, 2024
    Mar 31, 2024-$0.66-$0.68-$0.83 - -$0.50+2.94%BeatN/A120 up, 0 downMay 6, 2024
    Dec 31, 2023-$0.64-$0.77-$0.89 - -$0.67+16.88%BeatN/A121 up, 0 downFeb 26, 2024
    Sep 30, 2023-$0.75-$0.78-$0.93 - -$0.65+3.85%BeatN/A120 up, 0 downNov 6, 2023
    Jun 30, 2023-$0.82-$0.78-$0.88 - -$0.68-5.13%MissN/A100 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.73-$0.85-$0.96 - -$0.75+14.12%BeatN/A120 up, 0 downMay 4, 2023
    Dec 31, 2022-$0.89-$0.82-$1.00 - -$0.56-8.54%MissN/A140 up, 0 downFeb 27, 2023
    Sep 30, 2022-$0.87-$0.77-$0.90 - -$0.68-12.99%MissN/A130 up, 0 downNov 3, 2022
    Jun 30, 2022-$0.83-$0.68-$0.76 - -$0.59-22.06%MissN/A120 up, 0 downAug 8, 2022
    Mar 31, 2022-$0.67-$0.71-$0.79 - -$0.63+5.63%BeatN/A101 up, 0 downMay 5, 2022
    Dec 31, 2021-$0.69-$0.73-$1.10 - -$0.66+5.48%BeatN/A110 up, 0 downFeb 24, 2022
    Sep 30, 2021-$0.79-$0.62-$0.68 - -$0.56-27.42%MissN/A118 up, 0 downNov 3, 2021
    Jun 30, 2021-$0.55-$0.65-$0.75 - -$0.54+15.38%BeatN/A11N/AAug 9, 2021
    Mar 31, 2021-$0.65-$0.69-$1.01 - -$0.51+5.80%BeatN/A11N/AMay 10, 2021
    Dec 31, 2020-$1.08-$0.50-$0.57 - -$0.44-116.00%MissN/A13N/AFeb 25, 2021
    Sep 30, 2020-$0.53-$0.45-$0.51 - -$0.42-17.78%MissN/A11N/ANov 4, 2020
    Jun 30, 2020-$0.45-$0.50-$0.77 - -$0.42+10.00%BeatN/A9N/AAug 5, 2020
    Mar 31, 2020-$0.45-$0.45-$0.85 - -$0.380.00%In lineN/A8N/AMay 6, 2020
    Dec 31, 2019-$0.39-$0.49-$0.69 - -$0.40+20.41%BeatN/A8N/AMar 5, 2020
    Sep 30, 2019-$0.38-$0.51-$0.75 - -$0.39+25.49%BeatN/A9N/ANov 7, 2019
    Jun 30, 2019-$0.38-$0.61-$0.61 - -$0.40+37.70%BeatN/A7N/AAug 7, 2019
    Mar 31, 2019-$0.43-$0.62-$0.72 - -$0.49+30.65%BeatN/A7N/AMay 8, 2019
    Dec 31, 2018-$0.66-$0.44-$0.51 - -$0.40-50.00%MissN/A5N/AMar 7, 2019
    Sep 30, 2018-$0.40-$0.44-$0.50 - -$0.38+9.09%BeatN/A3N/ANov 7, 2018
    Jun 30, 2018-$0.40-$0.44-$0.44 - -$0.29+9.09%BeatN/A2N/AAug 8, 2018
    Mar 31, 2018-$0.28-$0.39N/A+28.21%BeatN/AN/AN/AMay 11, 2018
    Dec 31, 2017-$0.72-$0.31N/A-132.26%MissN/AN/AN/AMar 7, 2018
    Sep 30, 2017-$0.27N/AN/AN/AN/AN/AN/AN/ANov 8, 2017
    Jun 30, 2017-$0.96-$1.88N/A+48.94%BeatN/AN/AN/AAug 3, 2017
    Mar 31, 2017-$1.60-$1.57N/A-1.91%MissN/AN/AN/AMay 10, 2017
    Dec 31, 2016-$1.92-$1.73N/A-10.98%MissN/AN/AN/AMar 16, 2017
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.98, after -$2.73 the year before. It was -$6.40 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.98N/A
    Dec 31, 2024-$2.73N/A
    Dec 31, 2023-$2.94N/A
    Dec 31, 2022-$3.26N/A
    Dec 31, 2021-$2.68N/A
    Dec 31, 2020-$2.51N/A
    Dec 31, 2019-$1.58N/A
    Dec 31, 2018-$1.74N/A
    Dec 31, 2017-$3.55N/A
    Dec 31, 2016-$6.40N/A

    Frequently Asked Questions About RCKT

    When is Rocket Pharmaceuticals's next earnings date?

    Rocket Pharmaceuticals's next earnings report is expected for Feb 24, 2027.

    Did RCKT beat earnings estimates last quarter?

    No. Rocket Pharmaceuticals reported EPS of -$0.43 for the quarter ended Sep 30, 2026, below the -$0.39 estimate by 10.26%.

    What EPS do analysts expect from RCKT next quarter?

    The consensus EPS estimate for Rocket Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.42 from 15 analysts, with estimates from -$0.45 to -$0.25.

    How often does RCKT beat earnings estimates?

    Rocket Pharmaceuticals beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -15.62%.